Drug
Flotufolastat F 18
Flotufolastat F 18: highest development phase Phase 1, developed by Sinotau Pharmaceutical Group. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Sinotau Pharmaceutical Group
Trials
| Drug | Phase | Indication |
|---|---|---|
| Flotufolastat F-18 Injection NCT07149831 | Phase 1 | Prostate Cancer |
Latest
No recent events.
Follow Flotufolastat F 18 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.